Secondary Logo

Journal Logo

August 2012 - Volume 32 - Issue 4
pp: 437-582

Metabolic Effects of Paliperidone Extended Release Versus Oral Olanzapine in Patients With Schizophrenia: A Prospective, Randomized, Controlled Trial

Schreiner, Andreas; Niehaus, Dana; Shuriquie, Nasser Aldien; More

Journal of Clinical Psychopharmacology. 32(4):449-457, August 2012.

Effectiveness of a Cognitive Behavioral Weight Management Intervention in Obese Patients With Psychotic Disorders Compared to Patients With Nonpsychotic Disorders or No Psychiatric Disorders: Results From a 12-month, Real-World Study

Zhang, Jian-Ping; Weiss, Jeffrey J.; McCardle, Melissa; More

Journal of Clinical Psychopharmacology. 32(4):458-464, August 2012.

Human Abuse Potential and Cognitive Effects of Taranabant, a Cannabinoid 1 Receptor Inverse Agonist: A Randomized, Double-Blind, Placebo- and Active-Controlled, Crossover Study in Recreational Polydrug Users

Schoedel, Kerri A.; Addy, Carol; Chakraborty, Bijan; More

Journal of Clinical Psychopharmacology. 32(4):492-502, August 2012.

A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder

Ibrahim, Lobna; DiazGranados, Nancy; Jolkovsky, Libby; More

Journal of Clinical Psychopharmacology. 32(4):551-557, August 2012.

Efficacy and Safety of Levetiracetam for the Prevention of Alcohol Relapse in Recently Detoxified Alcohol-Dependent Patients: A Randomized Trial

Richter, Christoph; Effenberger, Susanne; Bschor, Tom; More

Journal of Clinical Psychopharmacology. 32(4):558-562, August 2012.

Functional Polymorphism of the Dopamine β-Hydroxylase Gene Is Associated With Increased Risk of Disulfiram-Induced Adverse Effects in Alcohol-Dependent Patients

Mutschler, Jochen; Abbruzzese, Elvira; Witt, Stephanie H.; More

Journal of Clinical Psychopharmacology. 32(4):578-580, August 2012.